Tiered AI Agent Orchestrator with Task-Appropriate Model Routing
C7/10June 12, 2026
WhatA middleware layer that automatically routes coding tasks to the most cost-effective AI model based on task complexity, using a frontier model only when simpler models would fail.
SignalDevelopers are manually switching between expensive frontier models for complex tasks and cheaper models for simple ones, expressing frustration that the most capable agents wastefully apply maximum effort to trivial problems — and that choosing the right model per task is a constant cognitive burden.
Why NowThe proliferation of model tiers (Fable, Opus, Sonnet, GPT-5.5, GPT-5.4) with dramatically different cost-capability profiles has made model selection a real optimization problem, but no tooling exists to automate the decision.
MarketEngineering teams and individual developers spending $200+/mo on AI coding tools; potentially a platform play capturing a percentage of optimized spend. Competes with manual model switching in IDEs — no automated solution exists yet.
MoatA growing dataset of task-complexity-to-model-success mappings creates an increasingly accurate routing engine that no new entrant can replicate without equivalent scale of real-world task data.
CRISPR Delivery Platform for Solid Tumor TherapeuticsP7/10A biotech company focused specifically on solving the delivery problem for CRISPR-based cancer therapies, developing novel lipid nanoparticle or viral vector systems that can efficiently transport CRISPR payloads to solid tumors in vivo.
CRISPR Cancer Diagnostics for Undruggable MutationsP6/10A diagnostic platform that profiles patients' tumors for the specific genomic amplifications and mutations that CRISPR-shredding approaches can target, enabling oncologists to match patients to emerging CRISPR therapies.
Biotech Translation Tracker for Informed InvestorsC5/10A platform that tracks the real progress of preclinical and clinical-stage biotech breakthroughs — from lab results through delivery challenges, trial phases, and regulatory milestones — giving investors and patients an honest, hype-free assessment of how close therapies actually are to market.
Viral Vector Therapy Development Platform as ServiceC6/10A contract development platform that helps biotech startups and academic labs design, optimize, and manufacture viral vector (AAV/lentivirus) delivery systems for gene therapies, positioning as the picks-and-shovels play in gene therapy.
Automated Cost Guardrails for AI Agent OperationsP7/10A middleware layer that sits between AI agents and cloud/API services, enforcing hard spending limits, rate controls, and anomaly detection before any resource is consumed.
Prepaid Spending Caps for Cloud and API ServicesC6/10A financial wrapper service that lets developers provision hard-capped, prepaid budgets for cloud and API usage — once the balance hits zero, all calls stop instantly.